SNDX

Syndax Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$25.15

Market Cap

$2.22B

Beta

0.41

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+627.84%

EPS Growth (YoY)+11.53%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-14.57%

Debt / Equity5.36

Interest Coverage-3.8x

No credit card required

Already have an account? Sign in to view the full analysis for SNDX.